We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+4.62%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$97.1B
AUM Growth
+$3.73B
Cap. Flow
-$572M
Cap. Flow %
-0.59%
Top 10 Hldgs %
29.21%
Holding
7,380
New
424
Increased
3,249
Reduced
2,816
Closed
405

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$637M
2
WY icon
Weyerhaeuser
WY
+$340M
3
IQV icon
IQVIA
IQV
+$132M
4
HAL icon
Halliburton
HAL
+$123M
5
DOV icon
Dover
DOV
+$112M

Sector Composition

Rank Sector Weight
1 Technology 6.22%
2 Healthcare 5.12%
3 Financials 4.53%
4 Consumer Discretionary 4.09%
5 Communication Services 3.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GBT
6276
PUT
DELISTED
Global Blood Therapeutics, Inc.
GBT
$6K ﹤0.01%
200
-5,100
-96% -$143K
PTR
6277
PUT
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
$6K ﹤0.01%
+100
New +$6.34K
TREC
6278
DELISTED
Trecora Resources
TREC
$6K ﹤0.01%
454
+440
+3,143% +$5.34K
SRGA
6279
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$6K ﹤0.01%
43
-295
-87% -$44.5K
PVG
6280
DELISTED
PRETIUM RESOURCES INC.
PVG
$6K ﹤0.01%
701
-2,799
-80% -$25.1K
CSLT
6281
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$6K ﹤0.01%
1,483
+714
+93% +$2.94K
MRLN
6282
DELISTED
Marlin Business Services Corp
MRLN
$6K ﹤0.01%
204
+199
+3,980% +$5.2K
ESXB
6283
DELISTED
Community Bankers Trust Corporation
ESXB
$6K ﹤0.01%
599
-4,800
-89% -$41.2K
TLGT
6284
DELISTED
Teligent, Inc
TLGT
$6K ﹤0.01%
96
-249
-72% -$18.2K
TNAV
6285
DELISTED
Telenav Inc.
TNAV
$6K ﹤0.01%
1,008
-19,614
-95% -$136K
BSTC
6286
DELISTED
BioSpecifics Technologies Corp.
BSTC
$6K ﹤0.01%
131
-1,220
-90% -$58.4K
JCAP
6287
DELISTED
Jernigan Capital, Inc.
JCAP
$6K ﹤0.01%
307
+300
+4,286% +$6.16K
SHLO
6288
DELISTED
Shiloh Industries Inc
SHLO
$6K ﹤0.01%
585
+578
+8,257% +$5.17K
GCAP
6289
DELISTED
Gain Capital Holdings, Inc.
GCAP
$6K ﹤0.01%
929
+902
+3,341% +$5.87K
CORI
6290
DELISTED
Corium International, Inc.
CORI
$6K ﹤0.01%
567
+552
+3,680% +$4.88K
CALL
6291
CALL
DELISTED
magicJack VocalTec Ltd
CALL
$6K ﹤0.01%
900
-3,500
-80% -$25.6K
PLPM
6292
DELISTED
Planet Payment, Inc
PLPM
$6K ﹤0.01%
1,463
+786
+116% +$2.92K
MEET
6293
DELISTED
The Meet Group, Inc. Common Stock
MEET
$6K ﹤0.01%
1,552
+1,502
+3,004% +$6.4K
ARC
6294
DELISTED
ARC Document Solutions, Inc.
ARC
$6K ﹤0.01%
1,579
-27
-2% -$103
PHIIK
6295
DELISTED
PHI, Inc. Non-Voting Common Stock
PHIIK
$6K ﹤0.01%
551
+261
+90% +$2.84K
ACTG icon
6296
Acacia Research
ACTG
$428M
$5K ﹤0.01%
1,241
-1,290
-51% -$4.83K
AGYS icon
6297
Agilysys
AGYS
$2.97B
$5K ﹤0.01%
478
-1,616
-77% -$17K
ANIP icon
6298
CALL
ANI Pharmaceuticals
ANIP
$1.8B
$5K ﹤0.01%
100
ARES icon
6299
Ares Management
ARES
$28.9B
$5K ﹤0.01%
249
+132
+113% +$2.4K
BAK icon
6300
PUT
Braskem
BAK
$928M
$5K ﹤0.01%
200
-1,100
-85% -$27K

Similar funds

Barclays's Q3 2017 Portfolio in Review

As of Q3 2017, Barclays held 7,380 positions worth $97.1B, up 4% from $93.4B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Barclays's Q3 2017 filing shows 424 new, 3,249 increased, 2,816 reduced and 405 closed positions. Its largest new stake was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M. The largest sale was Invesco QQQ Trust, an estimated $3.68B.

By sector, the portfolio is most concentrated in Technology at 6.2% of assets, up from 6.1% a quarter earlier, followed by Healthcare and Financials.

  • Barclays's largest Q3 2017 buy was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M.
  • Barclays added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $637M increase.
  • Barclays's biggest Q3 2017 reduction was Invesco QQQ Trust, cutting an estimated $3.68B.
  • Barclays fully exited Reynolds American Inc in Q3 2017, selling an estimated $293M.
  • Barclays's ten largest holdings make up 29% of its $97.1B portfolio in Q3 2017.
  • Barclays opened 424 new positions and closed 405 in Q3 2017.
  • Barclays's portfolio value rose 4% quarter-over-quarter to $97.1B.

Based on Barclays's 13F filing for Q3 2017, filed 14 Nov 2017.